Hepatitis C assay utilizing recombinant antigens
US6593083B1 · kind B1 · utility
0Cited by
1References
26Claims
0Family size
Inventors
Key dates
| Filing date | Oct 17, 2000 |
| Grant date | Jul 15, 2003 |
| Priority date | — |
| Expiry date | Oct 17, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Unique recombinant antigens representing distinct antigenic regions of the Hepatitis C Virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to HCV. The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.